who discovered glp 1 agonists Evolution of GLP‐1 Receptor for Diabetes Treatment GLP-1 | Summary
Description
That is why these injections are used in both type 2 diabetes and obesity management
This simple combination is often more satisfying than reaching for a pastry alone
Gradual escalation over 16 to 20 weeks is the standard clinical protocol precisely because it minimizes GI symptoms while still reaching a therapeutic dose
For instance, the STEP 1 extension study found that participants regained about two-thirds of their lost weight within a year of stopping semaglutide
GLP-1R agonists cannot be currently recommended as targeted approaches for MASH but should be administered for their indications (T2D, obesity)
